ADIAL PHARMACEUTICALS
Adial Pharmaceuticals engages in the development of prescription medications for addiction and related disorders in the United States. The company's research pipeline includes AD04, a compound that completed the Phase IIb study for the treatment of alcohol use disorders; and AD01, which completed the Phase I clinical-stage for treating addictive behaviors.
ADIAL PHARMACEUTICALS
Industry:
Addiction Treatment Biotechnology Health Care Pharmaceutical
Founded:
2010-01-01
Address:
Charlottesville, Virginia, United States
Country:
United States
Website Url:
http://www.adialpharma.com
Total Employee:
11+
Status:
Active
Contact:
434-422-9800
Email Addresses:
[email protected]
Total Funding:
34.32 M USD
Technology used in webpage:
Amazon Facebook Sharer Amazon California Region
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
TowerView Health
TowerView Health develops an application for patients to manage medications.
Trevarx Biomedical
Trevarx Biomedical is a biomedical startup that develops new radiopharmaceuticals.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Keystone Capital Partners
Keystone Capital Partners investment in Post-IPO Equity - Adial Pharmaceuticals
Richard Gilliam
Richard Gilliam investment in Post-IPO Equity - Adial Pharmaceuticals
Bespoke Growth Partners
Bespoke Growth Partners investment in Post-IPO Equity - Adial Pharmaceuticals
Keystone Capital Partners
Keystone Capital Partners investment in Post-IPO Equity - Adial Pharmaceuticals
Key Employee Changes
| Date | New article |
|---|---|
| 2024-01-18 | Adial Pharmaceuticals appoints Tony Goodman as COO |
| 2022-08-22 | Adial Pharmaceuticals Names Cary Claiborne as Chief Executive Officer |
Official Site Inspections
http://www.adialpharma.com
- Host name: 172.67.178.165
- IP address: 172.67.178.165
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Adial Pharmaceuticals"
Company – Adial Pharmaceuticals Inc.
Adial History. Adial Pharmaceuticals was founded in 2010, following pioneering research into the genetics of addiction that began in the 1990s. The research focused on the potential of a …See details»
Adial Pharmaceuticals Inc. | ABOUT
Adial Pharmaceuticals was founded on November 23, 2010 in Charlottesville, Virginia to develop and commercialize medications for the treatment of addictions and related disorders.See details»
Adial Pharmaceuticals Inc. | MANAGEMENT
William B. Stilley has served as our Chief Executive Officer since co-founding the company in December 2010. Prior to joining Adial Pharmaceuticals, he was the Vice President, Business …See details»
Adial Pharmaceuticals Inc. | BOARD OF DIRECTORS
He has guest lectured at the Darden School of Business in two courses on the management of life science companies, and serves on the Advisory Board of Virginia BIO, the statewide …See details»
Adial Pharmaceuticals - Crunchbase Company Profile & Funding
Organization. Adial Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Adial Pharmaceuticals develops …See details»
Adial Pharmaceuticals (NASDAQ: ADIL) - LinkedIn
Adial Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of treatments for addictions. The Company’s lead investigational new drug product, AD04, is a ...See details»
Adial Pharmaceuticals and Tedor Pharma Announce Collaboration …
Jun 6, 2019 Tedor is a full-service, end-to-end, contract development and manufacturing organization (CDMO) founded in 2001 that operates a 40,000 square foot cGMP solid dose …See details»
Adial Pharmaceuticals - Overview, News & Similar companies
May 15, 2024 Adial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark Office GLEN ALLEN, Va., April 22, 2024 (GLOBE NEWSWIRE) -- Adial …See details»
Adial Pharmaceuticals Inc, ADIL:NAQ profile - FT.com
Nov 8, 2024 Adial Pharmaceuticals Inc (ADIL:NAQ) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more.See details»
Adial Pharmaceuticals Inc. | About Adial
Page-template-default,page,page-id-16445,bridge-core-2.5.8,ajax_fade,page_not_loaded,,qode-theme-ver-24.3,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,wpb-js …See details»
Company Info – Adial Pharmaceuticals Inc.
Adial Pharma Contact Adial Pharmaceuticals, Inc. 4870 Sadler Road, Suite 300 Glen Allen, VA 23060 T: 1-804-487-8196 [email protected]See details»
Adial Pharmaceuticals Closes Acquisition of Purnovate
Jan 26, 2021 www.adialpharma.com About Purnovate, Inc. Purnovate, Inc., a wholly-owned subsidiary of Adial Pharmaceuticals, is a pharmaceutical development and chemistry company …See details»
Adial Pharmaceuticals Reports CEO Op-Ed Featured on Nasdaq.com
CHARLOTTESVILLE, Va., July 29, 2021 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW), a clinical-stage biopharmaceutical company focused on the …See details»
MEDICINES FOR ADDICTION - Adial Pharma
Jun 10, 2021 6 Kevin Schuyler, Vice Chairman & Lead Independent Director –Senior Managing Director, Cornerstone Partners, which manages public market investments for endowments, …See details»
Adial Pharmaceuticals Closes Acquisition of Purnovate - Nasdaq
Jan 26, 2021 Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on the development of treatments for addictions, has closed the acquisition of Purnovate, LLC, …See details»
Adial Pharmaceuticals Reports CEO Op-Ed Featured on
Jul 29, 2021 Additional information is available at www.adialpharma.com. About the Landmark ONWARD™ Pivotal Phase 3 Clinical Trial. The ONWARD trial is a 24-week, multicenter, …See details»
Adial Pharmaceuticals, Inc. (ADIL) - Yahoo Finance Canada
Find the latest Adial Pharmaceuticals, Inc. (ADIL) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
Adial Pharmaceuticals Inc. | TECHNOLOGY
The Company’s lead compound AD04 (“AD04”) is a genetically targeted therapeutic agent for the treatment of Alcohol Use Disorder (AUD) and is currently being investigated in a Phase 3 …See details»
Pipeline – Adial Pharmaceuticals Inc.
Close Phase 3. Phase 3 trials are conducted in patients with the disease. They are intended both to demonstrate the drug candidate’s positive effect in treating the target disease or disorder …See details»